High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: A crossover randomized clinical trial

Journal of Pediatric Gastroenterology and Nutrition

Volumn 22, Issue 1, 1996, Pages 73-78

  Lancellotti, Laura ^a   Cabrini, Giulio ^a   Zanolla, Luisa ^a   Mastella, Gianni ^a  

^a MAGGIORE HOSPITAL   (Italy)

Author keywords

Cystic fibrosis; Fat excretion; High strength pancreatic preparation; Pancreatic enzymes; Pancreatic insufficiency; Steatorrhea

Indexed keywords

AMYLASE; ANTACID AGENT; BICARBONATE; BILE ACID; CHOLECYSTOKININ; HISTAMINE H2 RECEPTOR ANTAGONIST; NITROGEN; PANCREAS ENZYME; PANCRELIPASE; PROTEINASE; TAURINE; TRIACYLGLYCEROL LIPASE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON STENOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG FORMULATION; ENZYME ACTIVITY; FEMALE; FLATULENCE; GASTROESOPHAGEAL REFLUX; HUMAN; MALABSORPTION; MALE; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STEATORRHEA; STOMACH DISTENSION;

ADOLESCENT; ADULT; CHILD; CROSS-OVER STUDIES; CYSTIC FIBROSIS; DIETARY FATS; EXOCRINE PANCREATIC INSUFFICIENCY; FECES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LIPASE; LIPIDS; MALE; MICROSPHERES;

EID: 0030022571     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199601000-00012     Document Type: Article

References (20)

1. Chase HP, Long MA, Lavin MN. Cystic fibrosis and malnutrition. J Pediatr 1979;95:337-46.
2. Dune PR, Pencharz PB. Nutrition. Br Med Bull 1992;48:823-47.
3. Beverley DW, Kelleher J, Macdonald A, Littlewood JM, Robinson T, Walters MP. Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 1987;62:564-8.
4. Stead RJ, Skypola I, Hodson ME, Batten JC. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation. Thorax 1987;42:533-7.
5. Vyas H, Matthew DJ, Milla PJ. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. Eur J Pediatr 1990; 49:241-3.
6. Brady MS, Karyl R, Yen PL, Eigen H. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis. J Am Diet Assoc 1992;7:813-7.
7. Braggion C, Borgo G, Faggionato P, Mastella G. Influence of antiacid and formulation on effectiveness of pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 1987;62:349-56.
8. Taylor CJ. Colonic strictures in cystic fibrosis. Lancet 1994; 343:615-6.
9. Gibson LF, Cooke PE. A test for the concentration of electrolytes in sweat in cystic fibrosis of the pancreas, utilizing pilocarpine iontophoresis. Pediatrics 1959;23:545-9.
10. Silverman A, Roy CIC, Cozzetto FJ. Tests of fat absorption and metabolism. In: Pediatric gastroenterology and nutrition, Silverman A, ed. St. Louis; MO: C. V. Mosby 1971:511.
11. Jeejeboy KN, Ammed S, Kerck G. Determination of fecal fats containing both medium and long chain triglicerides and fatty acids. Clin Biochem 1970;3:157-61.
12. Peuchant E, Salles C, Jensen R. Valve of spectroscopic "fecalogram" in determining the etiology of steatorrhea. Clin Chem 1988;34:5-8.
13. Murphy JL, Wootton SA, Bond JA, Jackson AA. Energy content of stools in normal healthy controls and patients with cystic fibrosis. Arch Dis Child 1991;66:495-500.
14. Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol 1979;8:7-20.
15. Morrison G, Morrison J, Redmond A, Byers C, Mccracken K, Dodge JA. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Aliment Pharmacol Ther 1992;6:549-55.
16. Shah A, Dinwiddie R, Madge S, Prescott P, Hudson G. High dose nutrizym 22 in cystic fibrosis. Eur J Pediatr 1993;152: 763-4.
17. Smyth RL, Van Velzen D, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994;343:85-6.
18. Maguire S, Goodchild MC. Enzyme contents of pancreatic extracts preparations. Drugs 1992;44:685-9.
19. Kraisinger M, Hochlaus G, Stecenko A, Bowser E, Hendeles L. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations. J Clin Pharmacol 1994;34: 158-66.
20. Bowler JM, Wolfe SP, Owens HM, Sheldon TA, Littlewood JM, Walters MP. A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis. Arch Dis Child 1993;68:227-30.